Danaher Corporation (US) and Sartorius AG (Germany) are Leading Players in the Continuous Bioprocessing Market
The continuous bioprocessing market is projected to reach USD 599 million by 2028 from an estimated USD 218 million in 2023, at a CAGR of 22.4% during the forecast period. The major factors driving the growth of this continuous bioprocessing market include the rising demand for biopharmaceuticals, growing adoption among CDMOs and CMOs, advantages of continuous bioprocessing over batch/fed-batch mode, favorable regulatory & government support for innovative technologies, and emergence of integrated end-to-end continuous bioprocessing.
The global continuous bioprocessing market is highly consolidated with top players such as Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (US), Repligen Corporation (US), and Merck KGaA (Germany). The market players have adopted various strategies such as new product launches, acquisitions, collaborations, and geographical expansions to strengthen their position in the global continuous bioprocessing market.
To know about the assumptions considered for the study download the pdf brochure
Danaher Corporation (US)
Danaher Corporation is a global science and technology innovator company and a competitive player in the continuous bioprocessing market. Through its subsidiary Cytiva that operates under Biotechnology business segment, Danaher offers advanced bioprocessing products such as cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish, as well as single-use hardware and consumables for upstream, downstream, and formulation & filling applications. The company has a strong emphasis on research; the company invested around USD 1.5 billion in research & development in 2022. The company’s research & development, manufacturing, sales, distribution, service, and administrative facilities are in more than 60 countries. Cytiva opened a new manufacturing facility in Cardiff, Wales. This makes Danaher a strong competitor in the continuous bioprocessing market.
Sartorius AG (Germany)
Sartorius will be a leading player in the continuous bioprocessing market in 2022. The company provides bioreactors, chromatography systems, filtration systems, and other products for continuous processing. The company maintains its leading position in the market by adopting strong organic growth strategies and acquiring some of the latest technology providers in the continuous bioprocessing market. Sartorius acquired Novasep’s Chromatography division in 2022. The company is further growing its global production capacity. The company’s wide presence across the globe plays a very important role in securing its position in the market.
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific Inc. is a well-established player in this market. The company provides single-use bioreactors and associated products for continuous bioprocessing. To meet the rising demand for bioprocessing solutions, Thermo Fisher focuses on increasing its capacity to produce single-use technologies by opening new manufacturing sites in the US. The company’s wide presence worldwide plays a key role in securing its position in the market.
Related Reports:
Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
